Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
Oak vs REMEVi
Oak and REMEVi both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Oak
Ranked #53 for women · Grade C
Luna Fit
Best for: Women who would rather buy a package outright than manage a recurring plan, and who are willing to complete a long health intake before finding out what they will actually be charged.
Visit OakREMEVi
Higher scoreRanked #32 for women · Grade B
Luna Fit
Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.
Visit REMEViThe verdict for women
REMEVi edges out Oak on the Luna Fit Score, 85 to 72 (B vs C). Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing. The reasoning behind that number is in the REMEVi scorecard.
Oak is still a genuine option — a compounded program sold as one-off packages rather than a subscription, in Spanish as well as English, charging $200/mo for semaglutide and $250 for tirzepatide at one flat rate per dose — but its own pages give nine different starting figures, none carrying a term and none of them the price it actually charges, plus two different answers on how many states it serves. Weigh the six women's-health factors below against your own priorities; our full Oak review goes through each of them, and if neither of these two is the one, the Oak alternatives, scored on the same six factors widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Oak | REMEVi |
|---|---|---|
| Luna Fit Score | 72/100 · C | 85/100 · B |
| Overall rank | #53 | #32 |
| Semaglutide | $250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning | $199/mo |
| Tirzepatide | $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning | $269/mo |
| Coverage | No state list published — Oak's own checkout accepts all 50 states and DC; its Terms of Use say 45 | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Luna Fit
Oak
Ranked #53 · Grade C
What we like
- No membership or subscription fee and no plan to manage — Oak sells one-month and three-month packages, with shipping included
- Oak's own checkout currently accepts every state and Washington D.C., and the site and the intake are offered in Spanish as well as English
- There is no recurring charge to stop, so there is nothing to cancel and no auto-renewal to catch you out
The caveats
- Oak does not publish a price you can act on. Across its own pages it gives nine different "starting" figures — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term or a billing cadence to none of them
- The two cheapest of those figures are not monthly rates. "Semaglutide from $119 / Tirzepatide from $185" appears only beside a "$200 off — new patient offer", and Oak's own affiliate page defines that offer as "$50 off your first month, $200 off 3-months" — a three-month package discount printed as if it were a per-month price
- The undiscounted floors Oak itself publishes are $190/mo on its weight-loss page and $167/mo in the comparison table on its homepage, and those two do not agree with each other either
Luna Fit
REMEVi
Ranked #32 · Grade B
What we like
- LegitScript-accredited and available in all 50 states
- Both molecules disclosed, tirzepatide for insulin-resistant PCOS
- Clear, predictable pricing
The caveats
- Higher-end pricing — $199 semaglutide, $269 tirzepatide
- No oral or brand-name option; general program without hormone specialization
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Oak nor REMEVi is only worth comparing with the other. Oak is also written up against CoreAge Rx, 21 points apart on the Luna Fit Score — see how Oak and CoreAge Rx compare on the Luna Fit Score. REMEVi is also written up against CoreAge Rx, 8 points apart — see the REMEVi–CoreAge Rx head-to-head.
- Oak vs CoreAge Rx
- Oak vs Enhance MD
- Oak vs Eden
- REMEVi vs yourEra
- REMEVi vs Sesame Care
- REMEVi vs HealthRX
Or browse the full comparison hub.